• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Federal Equipment Company

    Lannett CDMO

    Syngene International Ltd.

    Bachem

    INCOG BioPharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Federal Equipment Company

    Lannett CDMO

    Syngene International Ltd.

    Bachem

    INCOG BioPharma Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    The Future of Pharmaceutical Manufacturing

    Neo PLM’s Cathal Strain discusses the need for a digital revolution to drive manufacturing innovation

    The Future of Pharmaceutical Manufacturing
    Kristin Brooks, Contract Pharma02.12.20
    In an industry that tends to lag behind others on matters of technology transformation, today’s market pressures are creating an increasingly imperative need for change in pharmaceutical manufacturing practices. The pharmaceutical industry is heavily regulated, and therefore, inherently more complex. An overhaul of operations into the digital era can be disruptive to the supply of life-saving medicines.  

    However, in order to address the challenges that innovative therapeutics, pricing pressures, and global supply chains present, the adoption of digital solutions has become essential. This means moving beyond all paper-based document management systems, leveraging Big Data, artificial intelligence, industrial internet of things (IIoT), and machine-learning for a meaningful impact on pharmaceutical manufacturing to improve processes and quality.

    Cathal Strain, President of Neo PLM, a provider of Product Lifecycle Management solutions for pharmaceutical companies and process manufacturers, discusses the need for change in manufacturing practices and the next generation of technology that can help drive innovation.  –KB

    Contract Pharma: What are the latest breakthrough technologies being implemented by pharmaceutical manufacturers?

    Cathal Strain: Despite an abundance of innovation in new drug therapies, this century has not seen a corresponding adoption of truly breakthrough pharmaceutical manufacturing technologies. In the small molecule sector—the industry’s largest—continuous manufacturing is now a focus area, especially in new drug development. However, that focus has yet to yield any significant advances. The evolution pattern recalls that of process analytical technology (PAT), whose implementation has substantially lagged expectations after starting with great fanfare in the early 2000s. In the large molecule sector, the rise of single-use technologies is seen as a significant trend, at least for lower-volume manufacturing.

    However, none of these initiatives would qualify as a “breakthrough.” At best, the last two decades have been a period of slow evolution for pharma manufacturing in terms of new technology adoption. It is time for Big Pharma to fundamentally change the way it thinks about manufacturing.

    There was a time when pharma companies eagerly embraced emerging technologies, such as automation, to evolve their manufacturing operations. That was before the great shift to outsourced production began some 25 years ago. Since then, the industry's appetite for manufacturing innovation has diminished. The manufacturing supply chain remains mired in paper-based processes and production records—starting with initial tech transfer from R&D and continuing throughout the product lifecycle.

    CP: How is digitization impacting manufacturing operations?

    CS: Digitization, or digital transformation, is the buzzword of this era. However, discussing digitization in pharma manufacturing is difficult considering the paper-based paradigm that continues to dominate shop floors and critical business processes. Many software vendors are casting their products as pathways to digitization, but the same technologies have essentially been available for the past 30 years. These technologies provide a necessary foundation, but the reality is that digitization has not begun to impact pharmaceutical manufacturing operations in a meaningful way.

    CP: What are some of the critical factors for success? What hurdles must be overcome?

    CS: For myriad reasons, pharma manufacturers must move aggressively to participate in the digital revolution that began in other industries—and the consumer world—over 20 years ago. The biggest barrier to progress is the fact that pharma executives have seen no urgent need to evolve their manufacturing operations. Ongoing innovation is critical in other industries, driving the cost reductions and product quality improvements that companies need to survive and compete. However, pharma manufacturing has not been exposed to those same pressures. The industry can still afford inefficiency and regulatory authorities continue to accept antiquated paper-based processes.

    Another hurdle—rarely discussed in the open—is the notion that increasing transparency into pharma manufacturing may reveal problems that could, in turn, present regulatory risks. This attitude must change. Scientists and engineers are driven to uncover and solve manufacturing problems to improve product quality and plant productivity. They can only achieve these objectives with access to comprehensive digital data and advanced analytical tools.

    Pharma must make up a great deal of ground quickly to truly enter the digital age:

    •    Paper- and document-based business processes, from initial product development through shop floor manufacturing, must become obsolete.

    •    Product definition and process knowledge management must be completely digitized. Again, this must occur throughout the product lifecycle, starting with initial tech transfer from R&D. And digital transformation is about more than implementing document management systems. It means placing digital process design, modeling and simulation at the center of the manufacturing systems architecture.

    •    Manufacturers must deploy much more robust measurement and control systems on the shop floor. Just as automation has revolutionized other manufacturing industries, recipe-based automation is the only pathway to innovation in drug making. Advanced automation will be an essential component of continuous manufacturing, wherever that technology will be used.

    •    With a strong foundation in place, pharma will be well positioned to achieve full digital transformation. Newer technologies that fall under the “Big Data” umbrella—such as cloud-based services, the industrial internet of things (IIoT), artificial intelligence and machine-based learning—will become accessible and drive a new era of innovation.

    CP: Taking into consideration the unique challenges the pharmaceutical industry faces bringing operations into the digital era, what steps can it take to minimize the disruption of the supply of medicines?

    CS: The dilemma facing pharma manufacturers is digitizing their operations without disrupting the supply chain or raising regulatory concerns. A phased approach to digital transformation can help strike this balance.

    We have established the need to replace document-based approaches to tech transfer, process knowledge management and quality assurance with an integrated digital structure that puts process design, modeling and simulation at the center of the IT architecture. This shift is foundational to digital transformation, but will require significant business process re-engineering. The good news is that it can be achieved without negatively impacting shop floor operations. On the contrary, a digital design-centric approach will enhance shop floor operations substantially by automating the creation of recipes for manufacturing execution and control systems.

    That said, pharma manufacturers have underachieved when it comes to implementing the shop floor technologies required to enable fully recipe-driven manufacturing operations. The necessary level of process automation cannot be attained quickly. One step pharma manufacturers can take toward shop floor digitization—while not ideal—is implementing MES to achieve a paperless, Electronic Batch Record environment. MES vendors must do their part by providing more innovative solutions that allow customers to deploy EBR cost-effectively. Manufacturers should ultimately be striving for end-to-end process automation. To enable this transition, control system vendors must also make their wares more accessible from a cost standpoint.

    Finally, pharma manufacturers must digitize downstream activities such as batch review and release and advanced process analytics. That will open the door to leveraging the technologies driving Industry 4.0 such as IIoT, machine learning and artificial intelligence.

    CP: What do you anticipate for the future of the pharmaceutical manufacturing industry?

    CS: The FDA issued its industry guidance “Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach” in the early 2000s. That document encouraged the increased use of information and digital technologies—particularly PAT. In the intervening years, initiatives such as quality by design (QbD) and right-first-time manufacturing have received a great deal of attention. Yet for all this discussion, little has changed.

    Moving forward, however, the status quo is unsustainable. The workforce is increasingly comprised of those that are digital savvy. Pharma manufacturers cannot expect a laboriously document-intensive industry to inspire the finest engineering minds. To attract top talent, pharma manufacturers must empower their workforces with the best possible tools for the job. That means equipping shop floors with technologies that provide the comprehensive digital data necessary to truly ensure the highest product quality and manufacturing efficiency.

    Peter Drucker said, “You can only improve what you can measure.” Taking a step back, it is also true that you can only prove what you can measure—and that includes pharmaceutical product quality. Today’s paper records don’t prove much, no matter how many signatures they bear.

    It is time for pharma manufacturers to set their sights on the digital age. I anticipate they will.


    Cathal Strain is CEO of Neo PLM, the company that pioneered digital design-based Process PLM. Cathal founded Neo in 2011 with the vision of bringing third-millennium PLM capabilities to pharmaceutical companies and other process manufacturers. Today, leading pharmaceutical manufacturers are deploying Neo’s technology at sites around the world. Cathal previously spent over 30 years at Pfizer, where he led the design, development and implementation of the world’s first integrated PLM solution for process manufacturing.
    Related Searches
    • pharma companies
    • production
    • outsourced
    • mes
      Loading, Please Wait..
      Breaking News
      • Univercells Expands into the U.S. With New Offices in Andover, MA
      • Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
      • Ionis, Roche Partner on RNA-targeted Programs for AD and HD
      • Sanner Group Opens Second Manufacturing Facility in China
      • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
      View Breaking News >
      CURRENT ISSUE

      September 2023

      • Pharma Supply Chains: From Fragile to Agile
      • Overcoming Stressors in Knowledge Transfer
      • Innovations in Pharma Packaging
      • HPAPI Manufacturing Trends
      • Sustainable Packaging in Pharma: No Longer a Pipe Dream
      • Revolutionizing Pharma’s Supply Chain
      • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
      • Solving Pharma’s Underlying Rebate Leakage Problem
      • Advanced Manufacturing and a Roadmap to the Facility of the Future
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
      Natrol Launches First Non-Melatonin Sleep Supplement
      Metagenics Releases Consumer Survey on Menopausal Support Supplement
      Coatings World

      Latest Breaking News From Coatings World

      Coating Additives Market Worth $10.5B by 2028: MarketsandMarkets
      California Sports Surfaces Celebrates 70 Years
      ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MPO's Most-Read Stories This Week—Sept. 30
      Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
      SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Univercells Expands into the U.S. With New Offices in Andover, MA
      Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
      Ionis, Roche Partner on RNA-targeted Programs for AD and HD
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      MAV Beauty Recruits Former Elizabeth Arden CEO Scott Beattie
      YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
      74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
      Happi

      Latest Breaking News From Happi

      Is Dr. Barbara Sturm Skincare Considering a Sale?
      YSL Beauty Welcomes Five Foremost Artists to Represent New Fragrance
      Christian Siriano Appointed Olay’s First Chief Drop Officer
      Ink World

      Latest Breaking News From Ink World

      MicroDynamics, All Printing Resources Partner to Represent Veritas
      Weekly Recap: Wikoff Color, BASF, Latin America Top This Week’s Stories
      Siegwerk’s Climate Targets Validated by SBTi
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      SABIC and partners launch bio-based IML solution for food packaging
      tesa completes expansion of Michigan manufacturing facility
      Comexi and Asahi to host 'Effortless Platemaking' event
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Greentech Introduces Air Filter with Advanced Odor Elimination
      Ontex Divests Pakistan Operations to ASAIA Holding
      Goodnites Bedwetting Underwear Recognized by Good Housekeeping
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ODT's Most-Read Stories This Week—Sept. 30
      Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
      ChitogenX Granted New U.S., Canadian ORTHO-R Patent
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Weekly Recap: Mergers and Acquisitions, First Solar Top This Week’s Stories
      Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
      Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login